Clinical Trials

Accrual Status
Limit to SWOG Trials

1028 Results

    View
    Status Trial Number Title Activated Closed Accrual Phase Published
    Closed S0636 Phase II OSI-774/Bevacizumab in Neversmokers with St. IIIB and IV Primary NSCLC Adenocarcinoma 7/15/2007 9/1/2010 100%
    Closed S0535 Phase II ATRA, Arsenic and Mylotarg for Untreated High-Risk APL 11/15/2007 100%
    Closed S0518 CARCINOID Ph III depot octreotide + either interferon alpha or bevacizumab 12/1/2007 9/1/2012 100% Published
    Closed S0727 Pancreas Ph I/II gemcitabine, erlotinib, IMC-A12 3/1/2008 9/1/2010 100% Published
    Closed S0777 Phase III LD vs. VLD for Induction, followed by Transplant in Multiple Myeloma 4/1/2008 2/1/2012 100% Published
    Closed S0000D Adenomatous Colorectal Polyps (ACP) 6/3/2008 5/28/2013 100% Published
    Closed S0711 Dasatinib in patients with impaired hepatic function 10/15/2008 100%
    Closed S0720 Phase II Adjuvant NSCLC 11/15/2008 5/15/2012 100% Published
    Closed S0809 Cholangiocarcinoma Ph II capecitabine, gemcitabine, RT 12/1/2008 10/1/2012 100% Published
    Closed S0801 NON-HODGKIN: Bexxar + CHOP-Rituximab for Advanced Follicular NHL 4/1/2009 12/15/2010 100%
    Closed S0722 Phase II RAD001 in MPM 12/1/2008 9/15/2011 100% Published
    Closed S0702 CANCER CONTROL: Prospective ONJ Trial 12/15/2008 12/13/2013 100% Published
    Closed S0354 Advanced Prostate 4/1/2007 5/15/2008 100% Published
    Closed S0802 AVE0005 in E-SCLC, Randomized Ph II 5/15/2009 3/1/2012 100% Published
    Closed S0715 ALC 9/15/2009 2/1/2011 100% Published
    Closed S0816 Phase II Stage III-IV Hodgkin's: FDG-PET Imaging Study 7/1/2009 12/1/2012 100% Published
    Closed S0826 SCH 727965 Stage IV Melanoma 7/1/2009 11/1/2010 100%
    Closed S0919 Phase II Idarubicin/AraC + Pravastatin for Relapsed AML 8/15/2009 9/15/2017 100%
    Closed S0800 ADVANCED: Phase II weekly Nab-Paclitaxel +/- Bevacizumab, Preceded or Followed by AC+PEG-G for Locally Advanced Her-2/Neu Neg Breast Cancer 4/1/2010 10/1/2012 100% Published
    Closed S0805 Phase II HyperCVAD + Dasatinib with or without Allo SCT for Ph+ ALL 9/1/2009 100% Published
    Scroll Table